Evidence map›Paper›PMID 30397820›Full record

ReviewPharmaceutical research2018

A Review of the Emerging Role of Silk for the Treatment of the Eye.

Simon H Tran, Clive G Wilson, F Philipp Seib

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Pharmaceutical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06605365 completednot on this mapstarted 2021, after this paper: background citation

Ophthalmic Solution in Drye Eye Patients

Typeobservational_patient_registrySponsorD&V FARMA srlRan2021 to 2022Enrolled20ConditionsDry Eye Disease (DED)ArmsCX-HA and CS
NCT06840990 completednot on this mapstarted 2023, after this paper: background citation

Ophthalmic Solution in Corneal Re-epithelization

Typeobservational_patient_registrySponsorD&V FARMA srlRan2023 to 2024Enrolled20ConditionsCorneal Epithelial Wound HealingArmsCXC-SP, CTRL
3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Photobonding of silk fibroin-based hydrogels to rabbit corneas.Frontiers in bioengineering and biotechnology · 2025
    Article
  3. Review
  4. Seeing the Future: A Review of Ocular Therapy.Bioengineering (Basel, Switzerland) · 2024
    Review
  5. Review
  6. Review
  7. Protein and polypeptide mediated delivery to the eye.Advanced drug delivery reviews · 2022
    Review
  8. Article
  9. Article
  10. Sustained Release of Insulin-Like Growth Factor-1 fromInternational journal of molecular sciences · 2021
    Article
  11. Review
  12. Tissue Engineering Strategies for Retina Regeneration.Applied sciences (Basel, Switzerland) · 2021
    Article
  13. Review
  14. The Human Tissue-Engineered Cornea (hTEC): Recent Progress.International journal of molecular sciences · 2021
    Review
  15. Review
  16. Article
  17. Progressive trends in heavy metal ions and dyes adsorption using silk fibroin composites.Environmental science and pollution research international · 2020
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Simon H Tran37D Biosystems, Inc., 2372 Morse Avenue, Suite 433, Irvine, California, 92614, USA.
Clive G WilsonStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK.
F Philipp SeibStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, UK. philipp.seib@strath.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silk is a remarkable biopolymer with a long history of medical use. Silk fabrications have a robust track record for load-bearing applications, including surgical threads and meshes, which are clinically approved for use in humans. The progression of top-down and bottom-up engineering approaches using silk as the basis of a drug delivery or cell-loaded matrix helped to re-ignite interest in this ancient material. This review comprehensively summarises the current applications of silk for tissue engineering and drug delivery, with specific reference to the eye. Additionally, the review also covers emerging trends for the use of silk as a biologically active biopolymer for the treatment of eye disorders. The review concludes with future capabilities of silk to contribute to advanced, electronically-enhanced ocular drug delivery concepts.

Indexed as

AnimalsBiocompatible MaterialsDrug Delivery SystemsEye DiseasesHumansSilkTissue EngineeringWound HealingBiocompatible MaterialsSilkBombyx moridrug deliveryeyeocularsilk fibrointissue engineering

Identifiers

PMID30397820
PMCPMC6223815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.